IRIS
CITRARO, Rita
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.981
EU - Europa 1.487
AS - Asia 1.322
SA - Sud America 234
AF - Africa 36
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 8
Totale 6.097
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.788
SG - Singapore 671
IT - Italia 626
CN - Cina 325
DE - Germania 264
BR - Brasile 180
CA - Canada 164
FI - Finlandia 144
GB - Regno Unito 137
SE - Svezia 109
VN - Vietnam 64
IN - India 63
HK - Hong Kong 40
NL - Olanda 34
AU - Australia 27
TR - Turchia 26
JP - Giappone 24
ES - Italia 22
MX - Messico 19
RU - Federazione Russa 19
FR - Francia 18
AR - Argentina 16
UA - Ucraina 16
ID - Indonesia 15
ZA - Sudafrica 15
PL - Polonia 14
IL - Israele 12
BD - Bangladesh 11
CO - Colombia 11
CZ - Repubblica Ceca 11
GR - Grecia 11
RO - Romania 11
IR - Iran 10
AT - Austria 8
CH - Svizzera 8
PK - Pakistan 8
EC - Ecuador 7
MT - Malta 7
IQ - Iraq 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AE - Emirati Arabi Uniti 5
CL - Cile 5
EE - Estonia 5
EG - Egitto 5
KR - Corea 5
PT - Portogallo 5
HR - Croazia 4
PE - Perù 4
VE - Venezuela 4
AF - Afghanistan, Repubblica islamica di 3
BG - Bulgaria 3
EU - Europa 3
KE - Kenya 3
KZ - Kazakistan 3
NG - Nigeria 3
PH - Filippine 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
UY - Uruguay 3
BO - Bolivia 2
CY - Cipro 2
HN - Honduras 2
JM - Giamaica 2
LK - Sri Lanka 2
LT - Lituania 2
MA - Marocco 2
MD - Moldavia 2
MN - Mongolia 2
NO - Norvegia 2
PY - Paraguay 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
GH - Ghana 1
HU - Ungheria 1
IE - Irlanda 1
KG - Kirghizistan 1
KW - Kuwait 1
MU - Mauritius 1
MY - Malesia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PW - Palau 1
RS - Serbia 1
SN - Senegal 1
TL - Timor Orientale 1
Totale 6.097
Salva come PNG Salva come JPEG
Città #
Chandler 430
Singapore 364
Dallas 310
Munich 230
Santa Clara 179
Hefei 166
Milan 146
Princeton 128
Lawrence 127
Catanzaro 116
Ashburn 101
Ottawa 99
London 87
Wilmington 75
Chicago 72
Turku 68
Helsinki 67
Boardman 47
Des Moines 44
Hong Kong 39
Los Angeles 38
New York 32
Redwood City 31
Brooklyn 26
Montreal 22
São Paulo 22
Ho Chi Minh City 21
Tokyo 19
Shanghai 17
Guangzhou 16
Palermo 15
Rome 15
Norwalk 14
Boston 13
Florence 13
Melbourne 13
San Nicola Manfredi 13
Beijing 12
Johannesburg 12
Shenzhen 12
The Dalles 12
Warsaw 12
Amsterdam 11
Atlanta 11
Council Bluffs 11
Olomouc 11
Istanbul 10
Phoenix 10
Toronto 10
Hanoi 9
Bari 8
Messina 8
Naples 8
Padova 8
Pune 8
San Francisco 8
Stockholm 8
West Jordan 8
Ankara 7
Aversa 7
Chennai 7
Columbus 7
Curinga 7
Prato 7
Vienna 7
Assago 6
Augusta 6
Cosenza 6
Falls Church 6
Houston 6
Madrid 6
Mexico City 6
Nuremberg 6
Tel Aviv 6
Teresina 6
Vancouver 6
Casalnuovo di Napoli 5
Charlotte 5
Collegeville 5
Fayetteville 5
Haiphong 5
Jyväskylä 5
Montague 5
Reading 5
Redmond 5
Rende 5
Roccella Ionica 5
San Jose 5
Tashkent 5
Washington 5
Ann Arbor 4
Beauharnois 4
Brisbane 4
Clearwater 4
Giza 4
Newark 4
Nova Iguaçu 4
Ribeirão Preto 4
Riyadh 4
Sydney 4
Totale 3.667
Salva come PNG Salva come JPEG
Nome #
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 227
Palmitoylethanolamide modulates pentobarbital-evoked hypnotic effect in mice Involvement of allopregnanolone biosynthesis 128
First evidence of an altered microbiota and intestinal damage and its link to absence epilepsy in a genetic animal model, the WAG/Rij rat 112
Effects of chronic sodium alendronate on depression and anxiety in a menopausal experimental model 84
Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release 82
Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model 78
A Brain-To-SONAR Electronic Interface to Bypass Peripheral Auditory System in RATS 78
Cerebral small vessel disease predisposes to temporal lobe epilepsy in spontaneously hypertensive rats 67
Targeting alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors in epilepsy 66
Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice 63
Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study 62
Antiabsence effects of carbenoxolone in two genetic animal models of absence epilepsy (WAG/Rij rats and lh/lh mice) 61
Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsy 60
Metabolic and cognitive effects of ranolazine in type 2 diabetes mellitus: Data from an in vivo model 60
3D pharmacophore models for 1,2,3,4-tetrahydroisoquinoline derivatives acting as anticonvulsant agents 59
Increased efficacy of combining prebiotic and postbiotic in mouse models relevant to autism and depression 59
Amino acid levels in some brain areas of inducible nitric oxide synthase knock out mouse (iNOS(-/-)) before and after pentylenetetrazole kindling 58
N-acetylcysteine aggravates seizures while improving depressive-like and cognitive impairment comorbidities in the WAG/Rij rat model of absence epilepsy 58
Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy 57
IL-6 Receptor Blockade by Tocilizumab Has Anti-absence and Anti-epileptogenic Effects in the WAG/Rij Rat Model of Absence Epilepsy 57
Evaluation of the effects of liraglutide on the development of epilepsy and behavioural alterations in two animal models of epileptogenesis 57
Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity 57
T-type channel blocking properties and antiabsence activity of two imidazo [1,2-b]pyridazine derivatives structurally related to indomethacin 54
Preclinical activity profile of alpha-lactoalbumin, a whey protein rich in tryptophan, in rodent models of seizures and epilepsy 54
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy 54
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 54
Altered distribution and function of A2A adenosine receptors in the brain of WAG/Rij rats with genetic absence epilepsy, before and after appearance of the disease 53
Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP) 53
Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study 52
Alpha-lactoalbumin, a whey protein rich in tryptophan, is effective in rodent models of seizures and epileptogenesis 51
Protective activity of α-lactoalbumin (ALAC), a whey protein rich in tryptophan, in rodent models of epileptogenesis. 50
CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations 50
Metabolic Alterations Predispose to Seizure Development in High-Fat Diet-Treated Mice: the Role of Metformin 50
Pharmacokinetic considerations about antiseizure medications in the elderly 50
Bioinspired Electric Stimulation: Comparison of ECoG Spectrum in the Main Auditory Structures 49
Effects of Histone Deacetylase Inhibitors on the Development of Epilepsy and Psychiatric Comorbidity in WAG/Rij Rats 49
Cognitive impairment in the WAG/Rij rat absence model is secondary to absence seizures and depressive-like behavior 48
The Anticonvulsant Activity of a Flavonoid-Rich Extract from Orange Juice Involves both NMDA and GABA-Benzodiazepine Receptor Complexes 48
First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG/Rij rat 48
Antiepileptogenic effects of Ethosuximide and Levetiracetam in WAG/Rij rats are only temporary 47
The mTOR signaling pathway and neuronal stem/progenitor cell proliferation in the hippocampus are altered during the development of absence epilepsy in a genetic animal model 47
Enhancement of anti-absence effects of ethosuximide by low doses of a noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist in a genetic animal model of absence epilepsy 47
Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European Legislation  46
Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures 46
Direct Oral Anticoagulants: From Randomized Clinical Trials to Real-World Clinical Practice 46
Non-competitive AMPA glutamate receptors antagonism by perampanel as a strategy to counteract hippocampal hyper-excitability and cognitive deficits in cerebral amyloidosis 45
Effects of some neurosteroids injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy 45
A questionnaire-based study on prevalence and treatments of headache in Secondary Schools people of Catanzaro 45
Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy 45
HDL (High-Density Lipoprotein) and ApoA-1 Potentially Modulate Pancreatic α-Cell Glucagon Secretion 45
Epidemiology and outcomes of status epilepticus 45
Oleil hydroxytyrosol (Htol) exerts anti-myeloma activity by antagonizing key survival pathways in malignant plasma cells 45
Microbiota-gut brain axis involvement in neuropsychiatric disorders 44
Nano‐hydrogel embedded with quercetin and oleic acid as a new formulation in the treatment of diabetic foot ulcer: A pilot study 44
Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study 43
Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects 43
Butyrate prevents valproate-induced liver injury: In vitro and in vivo evidence 43
Everolimus improves memory and learning while worsening depressive- and anxiety-like behavior in an animal model of depression 42
Immediate and controlled-release pregabalin for the treatment of epilepsy 42
Role of Histone Deacetylases (HDACs) in Epilepsy and Epileptogenesis 41
Pharmacovigilance in pharmaceutical companies: An overview 41
Antiepileptogenic effects of the selective COX-2 inhibitor etoricoxib, on the development of spontaneous absence seizures in WAG/Rij rats 41
Cannabidiol as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome. 40
The potential role of cannabinoids in epilepsy treatment. 40
Biomimetic Sonar for Electrical Activation of the Auditory Pathway 40
A Multiple Synergic Treatment for Non-Healing Ulcer Management in a Patient with Klippel–Trenaunay Syndrome 39
Genetically epilepsy-prone rats (GEPRs) and DBA/2 mice: Two animal models of audiogenic reflex epilepsy for the evaluation of new generation AEDs 39
Colchicine in Managing Skin Conditions: A Systematic Review 39
Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study 38
Effects of non-competitive AMPA receptor antagonists injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy 38
Real-World Safety Profile of Biologics Used in Rheumatology: A Six-Year Observational Pharmacovigilance Study in the Calabria Region 37
Vigabatrin has antiepileptogenic and antidepressant effects in an animal model of epilepsy and depression comorbidity 37
mTOR inhibition modulates epileptogenesis, seizures and depressive-like behavior in a genetic model of absence seizures and mild depression comorbidity: a role for inflammatory responses 37
mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis 37
Direct Modulation of High-Frequency Neural Oscillations in the Auditory Cortex Through Electrical Microstimulation Generated by PVDF Sensors 37
Can we ‘seize’ the gut microbiota to treat epilepsy? 37
Cenobamate enhances the anticonvulsant effect of other antiseizure medications in the DBA/2 mouse model of reflex epilepsy 36
Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study 36
Intestinal inflammation increases convulsant activity and reduces antiepileptic drug efficacy in a mouse model of epilepsy 36
Asthma control during COVID-19 lockdown in patients with severe asthma under biological drug treatment 36
Antidepressants drugs for seizures and epilepsy: Where do we stand? 35
Seizure susceptibility to various convulsant stimuli in the BTBR mouse model of autism spectrum disorders 35
Comparative Analysis of the Treatment of Chronic Antipsychotic Drugs on Epileptic Susceptibility in Genetically Epilepsy-prone Rats 35
Long-term betamethasone 21-phosphate disodium treatment has distinct effects in CD1 and DBA/2 mice on animal behavior accompanied by opposite effects on neurogenesis 35
Oral Metformin Ameliorates Bleomycin-Induced Skin Fibrosis 35
Are big potassium-type Ca2+-activated potassium channels a viable target for the treatment of epilepsy? 34
Pharmacokinetic-pharmacodynamic influence of N-palmitoylethanolamine, arachidonyl-2'-chloroethylamide and WIN 55,212-2 on the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice 34
Pharmacology of epileptogenesis and related comorbidities in the WAG/Rij rat model of genetic absence epilepsy 33
Statins and Epilepsy: Preclinical Studies, Clinical Trials and Statin-Anticonvulsant Drug Interactions 33
Liraglutide chronic treatment prevents development of tolerance to antiseizure effects of diazepam in genetically epilepsy prone rats 32
Effect of Statins on Lung Cancer Molecular Pathways: A Possible Therapeutic Role 32
Perampanel effects in the WAG/Rij rat model of epileptogenesis, absence epilepsy, and comorbid depressive-like behavior 32
Lamotrigine positively affects the development of psychiatric comorbidity in epileptic animals, while psychiatric comorbidity aggravates seizures 32
Pharmacodynamic potentiation of antiepileptic drugs' effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA/2 mice 32
Corrigendum to "Antiabsence effects of carbenoxolone in two genetic animal models of absence epilepsy (WAG/Rij rats and lh/lh mice)" (DOI:10.1016/j.neuropharm.2005.04.012) 32
Quercetin-3-Oleate Contributes to Skin Wound Healing Targeting FFA1/GPR40 32
An Open Retrospective Study of a Standardized Cannabidiol Based-Oil in Treatment-Resistant Epilepsy 32
Glucagon induces the hepatic expression of inflammatory markers in vitro and in vivo 32
An In Vivo Electroencephalographic Analysis of the Effect of Riluzole against Limbic and Absence Seizure and Comparison with Glutamate Antagonists 31
Oxygen–Ozone Therapy in Cervicobrachial Pain: A Real-Life Experience 31
Totale 4.913
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.769
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.769
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021337 0 0 20 30 22 145 42 9 38 11 15 5
2021/2022431 3 6 9 91 21 14 6 83 79 50 57 12
2022/20231.224 261 101 41 102 119 98 14 79 191 86 91 41
2023/2024729 120 89 63 59 54 120 31 46 11 47 29 60
2024/20252.139 261 71 104 88 142 267 162 93 236 69 265 381
2025/20261.256 304 448 504 0 0 0 0 0 0 0 0 0
Totale 6.352